CP
YCBD icon

Camelot Portfolios’s cbdMD YCBD Stock Holding History

Camelot Portfolios’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,250
Closed -$4.39K – 565
2025
Q4 		$4.39K Buy
+3,250
New +$3.27K ﹤0.01% 492

Other funds holding YCBD

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Camelot Portfolios's YCBD Position: Q1 2026 in Review

Camelot Portfolios sold out of cbdMD (YCBD) in Q1 2026, closing a stake of 3,250 shares — an estimated $4.39K sold.

Camelot Portfolios first reported a position in YCBD in Q4 2025 and held it in 1 quarter. The position peaked at $4.39K in Q4 2025. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Camelot Portfolios reported no remaining cbdMD position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 3,250 cbdMD shares in Q1 2026, an estimated $4.39K.
  • Camelot Portfolios first reported a position in cbdMD in Q4 2025 and held it in 1 quarter.
  • Camelot Portfolios's cbdMD position peaked at $4.39K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.